From candidate to default: the company has just been placed inside buyers' own purchasing systems
The model's full reasoning — Q1 2018 call → NO我们根据提供的财报电话会议记录,判断管理层是否描述了公司最近从“必须说服买家考虑”的候选者,转变为买家自身采购、报销、处方集、规格、采购、网络、目录或计划系统中的“已批准、指定、列出、合格、注册、报销或预授权”选择,从而使得公司未来业务的重要部分可以在无需为每笔订单进行单独销售活动的情况下到来,并且管理层传达这种准入状态是新的,以至于它所带来的大部分业务量仍尚未反映在已报告的结果中。 在记录中,管理层提到了几个可能相关的项目: 1. 纽约州宽带计划和Connect America Fund (CAF) 的资助奖励:Pradman Kaul说“我们收到了通知,我们被推荐获得纽约州宽带计划下的资助奖励,以及通过Connect America Fund (CAF) 计划的相关资金,可能涉及约5万户家庭。我们正在敲定这些奖励的最终细节以及与之相关的条款和条件,一旦最终确定,我们将提供更新。” 这听起来像是公司被推荐获得资助,但尚未最终确定。这属于“待定”状态,而不是已经获得批准并进入系统。此外,管理层没有说这已经导致业务量开始流入,而是说“正在敲定细节”,所以这更像是“申请中”或“待定”,而不是已经进入系统。 2. 关于OneWeb网关:Pradman Kaul说“OneWeb网关的开发和制造工作仍在继续,我们已经为前两个试点网关运送了设备,这些网关将用于验证系统与初始卫星。我们将在今年下半年开始生产和发货。正如之前宣布的,这是OneWeb价值3亿美元订单的一部分。” 这描述的是与OneWeb的现有合同关系,是常规的销售关系,而不是公司被纳入某种采购系统。这更像是普通的客户订单,每个订单仍需单独协商。 3. 关于SD-WAN:Pradman Kaul说“Hughes SD-WAN是分布式网络的正确解决方案。它是一种完全托管的服务,集成了传输、强大的安全性,并由Hughes专有的ActiveTechnologies提供支持。” 这描述的是产品特性,而不是公司被纳入某个系统。 4. 关于巴西和拉丁美洲的扩张:提到在巴西、哥伦比亚等地的服务,但这些都是常规的业务扩展,没有提到被纳入任何采购系统。 5. 关于EchoStar Mobile (EML):Anders Johnson说“我们还没有达到可以分享客户统计数据的商业活动水平。” 所以没有提到任何准入状态。 6. 关于DISH Mexico:没有提到。 在记录中,没有明确提到公司被添加到任何“批准供应商名单”、“首选供应商名单”、“处方集”、“报销目录”、“采购计划”等。提到的CAF和纽约州奖励是“推荐”和“正在敲定”,属于待定状态,而不是已经获得。此外,管理层没有说这些奖励已经导致业务量开始流入,而是说“一旦最终确定,我们将提供更新”,所以这更像是未来可能发生的事,而不是已经发生的事。 因此,根据提供的记录,管理层没有描述公司最近从候选者转变为已批准/指定/列出等状态,也没有说这种状态是新的且大部分业务量尚未反映在结果中。所以答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| WRBY | Warby Parker Inc. | Q1 2024 | 2024-05-09 | A |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| DXCM | DexCom, Inc. | Q4 2023 | 2024-02-08 | B+ |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| INGN | Inogen, Inc. | Q1 2023 | 2023-05-05 | F |
| HBB | Hamilton Beach Brands Holding Company | Q3 2022 | 2022-11-05 | C |
| EVGO | EVgo, Inc. | Q2 2022 | 2022-08-09 | C+ |
| OPK | OPKO Health, Inc. | Q1 2022 | 2022-05-09 | D |
| MGNI | Magnite, Inc. | Q1 2022 | 2022-05-04 | D |
| AGIO | Agios Pharmaceuticals, Inc. | Q3 2018 | 2018-11-01 | C |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
PRIM · Q2 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this shift for the newly acquired T&D segment: after the Willbros acquisition (closed June 1, 2018), the T&D Group gained access to major utilities that had been hesitant due to prior financial concerns. With Primoris as parent, they signed new awards from the 3 largest electrical utilities (one announced MSA, two not yet announced), allowing work to flow under existing relationships without repeated persuasion. Management explicitly ties this to the recent acquisition and notes the MSA backlog now at $1.1 billion (first time exceeding $1 billion), with one-year estimated MSA revenue at $1.1 billion and continued growth expected.
AGIO · Q3 2018 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, qua...YES The transcript shows management describing exactly this transition for TIBSOVO. Steve Hoerter states that the company launched in July 2018 and is now receiving reimbursement with “no payer-related coverage issues,” with the payer mix (60% Medicare, 35% commercial) reflecting routine placement in those systems. He further notes that initial prescriptions are being written by over 100 unique prescribers and that awareness is already above 90%, confirming the product has moved from candidate status into the reimbursement and purchasing pathways. Because the launch is only a few months old at the time of the call, the $4.
AZEK · Q2 2024 → YESThe question is about whether management describes that the company has recently crossed from being a candidate that buyers must be persuaded to consider into being an approved, specified, listed, etc...YES The transcript shows management describing recent and incremental shelf-space gains in both pro and retail channels as a new development that will support growth in 2025, with investments planned for Q4 to enable these gains. This is framed as moving beyond prior years' steady execution into fresh wins that create a tailwind for future 2025 volume, where the company is now positioned to benefit from expanded availability in buyer systems (catalogs, dealer networks, and retail displays) without needing to re-persuade for each order.